These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33432784)

  • 1. The association of lncRNA SNPs and SNPs-environment interactions based on GWAS with HBV-related HCC risk and progression.
    Liu Q; Liu G; Lin Z; Lin Z; Tian N; Lin X; Tan J; Huang B; Ji X; Pi L; Yu X; Liu L; Gao Y
    Mol Genet Genomic Med; 2021 Feb; 9(2):e1585. PubMed ID: 33432784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of long non coding RNA genes is associated with expression with polymorphisms of HULC rs7763881 and MALAT1 rs619586 in hepatocellular carcinoma and HBV Egyptian patients.
    Motawi TMK; El-Maraghy SA; Sabry D; Mehana NA
    J Cell Biochem; 2019 Sep; 120(9):14645-14656. PubMed ID: 31009106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variants identified by hepatocellular carcinoma and chronic hepatitis B virus infection susceptibility GWAS associated with survival in HBV-related hepatocellular carcinoma.
    Li C; Bi X; Huang Y; Zhao J; Li Z; Zhou J; Zhang M; Huang Z; Zhao H; Cai J
    PLoS One; 2014; 9(7):e101586. PubMed ID: 24987808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression quantitative trait loci in long non-coding RNA ZNRD1-AS1 influence both HBV infection and hepatocellular carcinoma development.
    Wen J; Liu Y; Liu J; Liu L; Song C; Han J; Zhu L; Wang C; Chen J; Zhai X; Shen H; Hu Z
    Mol Carcinog; 2015 Nov; 54(11):1275-82. PubMed ID: 25110835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus genotypes, expression quantitative trait loci for ZNRD1-AS1 and their interactions in hepatocellular carcinoma.
    Liu Z; Song C; Wen J; Xu L; Liu Y; Zhu J; Zhu L; Hu Z; Ma H; Liu L
    Oncotarget; 2016 Jul; 7(28):44076-44083. PubMed ID: 27286450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA F11-AS1 inhibits HBV-related hepatocellular carcinoma progression by regulating NR1I3 via binding to microRNA-211-5p.
    Deng Y; Wei Z; Huang M; Xu G; Wei W; Peng B; Nong S; Qin H
    J Cell Mol Med; 2020 Jan; 24(2):1848-1865. PubMed ID: 31880390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene polymorphisms of TLR2 and TLR3 in HBV clearance and HBV-related hepatocellular carcinoma in a Chinese male population.
    Chen D; Xie W; Lu Y; Su S; Nong L; Jia Y; Liu Y; Zhou W; Wang H; Tan A
    Int J Biol Markers; 2017 May; 32(2):e195-e201. PubMed ID: 28009434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between lncRNA-related polymorphisms and hepatocellular carcinoma risk: A two-stage case-control study.
    Li Y; He HC; Zhou DL; Liu Q; Zhang X; Yang XH; Ye ZL; Peng JL; Tang T; Su X; He CY
    J Gastroenterol Hepatol; 2021 Jan; 36(1):233-239. PubMed ID: 32453900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Mou Y; Wang D; Xing R; Nie H; Mou Y; Zhang Y; Zhou X
    Cancer Biomark; 2018; 23(1):95-106. PubMed ID: 29991128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A genetic variant in long non-coding RNA HULC contributes to risk of HBV-related hepatocellular carcinoma in a Chinese population.
    Liu Y; Pan S; Liu L; Zhai X; Liu J; Wen J; Zhang Y; Chen J; Shen H; Hu Z
    PLoS One; 2012; 7(4):e35145. PubMed ID: 22493738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis of long non-coding RNA expression profiles in hepatitis B virus-related hepatocellular carcinoma.
    Gong X; Wei W; Chen L; Xia Z; Yu C
    Oncotarget; 2016 Jul; 7(27):42422-42430. PubMed ID: 27285756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association between interleukin-18 gene polymorphisms and hepatocellular carcinoma caused by hepatitis B virus].
    Zhang QX; Yao YQ; Li SL; Long Q
    Zhonghua Gan Zang Bing Za Zhi; 2016 May; 24(5):352-7. PubMed ID: 27470888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
    Han Y; Pu R; Han X; Zhao J; Li W; Yin J; Zhang Y; Shen Q; Xie J; Zhang Q; Jiang S; Li J; Zhang H; Wang H; Cao G
    Liver Int; 2014 May; 34(5):728-36. PubMed ID: 24118778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of SNPs in lncRNA as ceRNA on the risk and prognosis of hepatocellular carcinoma.
    Mo H; Wang X; Ji G; Liang X; Yang Y; Sun W; Jia X; Xu L; Qiao Y; Zhou H; Zhao W; Fu S; Zhang X
    BMC Genomics; 2022 Nov; 23(1):769. PubMed ID: 36418931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
    Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma risk variant modulates lncRNA HLA-DQB1-AS1 expression via a long-range enhancer-promoter interaction.
    Wang H; Yang B; Cai X; Cheng X; Shen N; Liu L; Li J; Wang Y; He H; Ying P; Li B; Lu Z; Yang N; Wang X; Zhang F; Li Y; Wang W; Ning C; Zhu Y; Chang J; Miao X; Tian J; Zhong R
    Carcinogenesis; 2021 Nov; 42(11):1347-1356. PubMed ID: 34665859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development.
    Hu L; Zhai X; Liu J; Chu M; Pan S; Jiang J; Zhang Y; Wang H; Chen J; Shen H; Hu Z
    Hepatology; 2012 May; 55(5):1426-31. PubMed ID: 22105689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UBE2L3, a susceptibility gene that plays oncogenic role in hepatitis B-related hepatocellular carcinoma.
    Liu Y; Song C; Ni H; Jiao W; Gan W; Dong X; Liu J; Zhu L; Zhai X; Hu Z; Li J
    J Viral Hepat; 2018 Nov; 25(11):1363-1371. PubMed ID: 29969176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptome-wide association study for persistent hepatitis B virus infection and related hepatocellular carcinoma.
    Han J; Chen C; Wang C; Qin N; Huang M; Ma Z; Zhu M; Dai J; Jiang Y; Ma H; Jin G; Shen H; Hu Z
    Liver Int; 2020 Sep; 40(9):2117-2127. PubMed ID: 32574393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.